bet365bet365Have any questions? 706-721-6582 or [email protected]
| Study Name | Principal Investigator |
|---|---|
| A PHASE 2B/3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12 MONTH CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MN-166 (IBUDILAST) FOLLOWED BY AN OPEN-LABEL EXTENSION IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS | Rivner, Michael |
| Biorepository of ALS Samples | Barnes, Benjamin |
| HEALEY ALS Platform Trial | Rivner, Michael |
